296 related articles for article (PubMed ID: 36754655)
1. Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: Results from the NHANES study.
Xie ZQ; Li HX; Wang BK; Yang ZM; Zhang ZY; Tan WL; Li WX; Wang QB; Yang L; Zhuang HK; Tang CW; Shang CZ; Chen YJ
Eur J Intern Med; 2023 Apr; 110():62-70. PubMed ID: 36754655
[TBL] [Abstract][Full Text] [Related]
2. A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population.
Zhang YC; Lyu ZY; Ma B; Li LM; Wang W; Sheng C; Dai HJ; Huang YB; Song FF; Song FJ; Chen KX
Hepatol Int; 2022 Aug; 16(4):835-845. PubMed ID: 35701716
[TBL] [Abstract][Full Text] [Related]
3. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.
Kim D; Konyn P; Sandhu KK; Dennis BB; Cheung AC; Ahmed A
J Hepatol; 2021 Dec; 75(6):1284-1291. PubMed ID: 34380057
[TBL] [Abstract][Full Text] [Related]
4. Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population.
Lee H; Lim TS; Kim SU; Kim HC
Hepatol Int; 2022 Dec; 16(6):1308-1317. PubMed ID: 36070124
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
6. Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact.
Tang SY; Tan JS; Pang XZ; Lee GH
World J Gastroenterol; 2023 Jan; 29(3):549-560. PubMed ID: 36688021
[TBL] [Abstract][Full Text] [Related]
7. The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals.
Chan KE; Ng CH; Fu CE; Quek J; Kong G; Goh YJ; Zeng RW; Tseng M; Aggarwal M; Nah B; Chee D; Wong ZY; Zhang S; Wang JW; Chew NWS; Dan YY; Siddiqui MS; Noureddin M; Sanyal AJ; Muthiah M
Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2560-2569.e15. PubMed ID: 36202348
[TBL] [Abstract][Full Text] [Related]
8. Impact of Thyroid Function on the Prevalence and Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease.
Chen YL; Tian S; Wu J; Li H; Li S; Xu Z; Liang XY; Adhikari VP; Xiao J; Song JY; Ma CY; She RL; Li ZX; Wu KN; Kong LQ
J Clin Endocrinol Metab; 2023 Jun; 108(7):e434-e443. PubMed ID: 36637992
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis.
Muthiah M; Ng CH; Chan KE; Fu CE; Lim WH; Tan DJH; Nah B; Kong G; Xiao J; Yong JN; Tan B; Syn N; Wang JW; Sayed N; Tan E; Chew NW; Dan YY; Siddiqui MS; Sanyal AJ; Noureddin M
Ann Hepatol; 2023; 28(1):100762. PubMed ID: 36182031
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999-2016.
Zhang HJ; Wang YY; Chen C; Lu YL; Wang NJ
Chin Med J (Engl); 2021 Jun; 134(13):1593-1601. PubMed ID: 34091530
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Disease Risk and Statin Use Among Adults with Metabolic Dysfunction Associated Fatty Liver Disease.
Yeoh A; Cheung R; Ahmed A; Chitnis AS; Do A; Wong RJ
Am J Med; 2023 Jul; 136(7):669-676.e1. PubMed ID: 37001720
[TBL] [Abstract][Full Text] [Related]
12. Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003-2018.
Xie Z; Aimuzi R; Si M; Qu Y; Jiang Y
Front Public Health; 2023; 11():1133194. PubMed ID: 36950101
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, characteristics, and mortality outcomes of obese and nonobese MAFLD in the United States.
Dao AD; Nguyen VH; Ito T; Cheung R; Nguyen MH
Hepatol Int; 2023 Feb; 17(1):225-236. PubMed ID: 36309601
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease.
Cheng KL; Wang SW; Cheng YM; Hsieh TH; Wang CC; Kao JH
J Formos Med Assoc; 2024 Jan; 123(1):36-44. PubMed ID: 37491179
[TBL] [Abstract][Full Text] [Related]
15. Associations between metabolic dysfunction-associated fatty liver disease, chronic kidney disease, and abdominal obesity: a national retrospective cohort study.
Cen C; Fan Z; Ding X; Tu X; Liu Y
Sci Rep; 2024 Jun; 14(1):12645. PubMed ID: 38825630
[TBL] [Abstract][Full Text] [Related]
16. Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction-associated Fatty Liver Disease.
Huang H; Guo Y; Liu Z; Zeng Y; Chen Y; Xu C
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3295-e3303. PubMed ID: 35521833
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Dysfunction-Associated Fatty Liver Disease Is Associated with the Risk of Incident Cardiovascular Disease: A Prospective Cohort Study in Xinjiang.
Guo Y; Yang J; Ma R; Zhang X; Guo H; He J; Wang X; Cao B; Maimaitijiang R; Li Y; Peng X; Zhang S; Guo S
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745091
[TBL] [Abstract][Full Text] [Related]
18. Association of Stroke With Metabolic Dysfunction-Associated Fatty Liver Disease With and Without CKD.
Li Y; Wu S; Gao J; Zhang Y; Zuo Y; Tian X; Chen S; Xing A; Wang A; He Y
Am J Kidney Dis; 2024 Apr; 83(4):477-488. PubMed ID: 37838141
[TBL] [Abstract][Full Text] [Related]
19. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.
Liang Y; Chen H; Liu Y; Hou X; Wei L; Bao Y; Yang C; Zong G; Wu J; Jia W
J Clin Endocrinol Metab; 2022 Jan; 107(1):88-97. PubMed ID: 34508601
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease.
Moon JH; Kim W; Koo BK; Cho NH;
Gut Liver; 2022 May; 16(3):433-442. PubMed ID: 34635626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
